Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Juan E. Ferrario"'
Autor:
Javier Andrés Muñiz, Carolina Lucía Facal, Leandro Urrutia, Ramiro Clerici-Delville, Ana Damianich, Juan E. Ferrario, Germán Falasco, María Elena Avale
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Tau is a microtubule-associated protein predominantly expressed in neurons, which participates in microtubule polymerization and axonal transport. Abnormal tau metabolism leads to neurodegenerative diseases named tauopathies, such as Alzheimer’s di
Externí odkaz:
https://doaj.org/article/36ed0e9e232c4960b582dd1a46c7cdb2
Autor:
Camilo J. Mininni, Maria Elena Avale, German Falasco, Magdalena Ponce de Leon, Mariano Soiza-Reilly, Javier Andrés Muñiz, Leandro Urrutia, Carolina Lucia Facal, Ana Damianich, Juan E. Ferrario
Publikováno v:
Brain. 144:2302-2309
Tauopathies are neurodegenerative diseases caused by the abnormal metabolism of the microtubule associated protein tau (MAPT), which is highly expressed in neurons and critically involved in microtubule dynamics. In the adult human brain, the alterna
Autor:
Mariano D. Saborido, Oscar S. Gershanik, Juan E. Ferrario, Gimena Gomez, Irene R. E. Taravini, M. Alejandra Bernardi
Publikováno v:
Neuroscience Letters. 666:5-10
L-DOPA is the gold standard pharmacological therapy for symptomatic treatment of Parkinson´s disease (PD), however, its long-term use is associated with the emergence of L-DOPA-induced dyskinesia (LID). Understanding the underlying molecular mechani
Autor:
M. Alejandra Bernardi, Tomas Eidelman, Ana Damianich, Juan E. Ferrario, Oscar S. Gershanik, Sara Sanz-Blasco, M. Elena Avale, Melina Paula Bordone
Publikováno v:
eNeuro
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Visual Abstract
Dopamine replacement by levodopa (L-DOPA) is the most widely used therapy for Parkinson’s disease (PD), however patients often develop side effects, known as L-DOPA-induced dyskinesia (LID), that usually need therapeutic interv
Dopamine replacement by levodopa (L-DOPA) is the most widely used therapy for Parkinson’s disease (PD), however patients often develop side effects, known as L-DOPA-induced dyskinesia (LID), that usually need therapeutic interv
Autor:
Irene Rita Eloisa Taravini, Alejandra Bernardi, Marcela Schenk, Pedro Ballestero, Oscar S. Gershanik, Roy Rivero, Sandra N. Guerrero, Mariana Inés Ferrario, Gimena Gomez, Elena Avale, Juan E. Ferrario
The infusion from Ilex paraguariensis (popularly known as Yerba mate [YM]) produces the very popular South American beverage called mate (pronounced as “mateI” or maté), and its intake has been inversely associated with the development of Parkin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9be5653a2eab6a089f0619ebb3583cb
Wiley Online Library
Wiley Online Library
Autor:
Trinidad Saez, Lucas Eneas Cromberg, Matías Alloatti, Victorio Martin Pozo Devoto, María Gabriela Otero, Marcelo Rubinstein, Juan E. Ferrario, Tomás L. Falzone, Eugenia Tomasella, Ana Damianich, Diego Matias Gelman
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
The process of locomotion is controlled by fine-tuned dopaminergic neurons in the Substantia Nigra pars-compacta (SNpc) that projects their axons to the dorsal striatum regulating cortical innervations of medium spiny neurons. Dysfunction in dopamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578c2b62b25401827db346c600cf571c
http://doi.wiley.com/10.1111/jnc.14665
http://doi.wiley.com/10.1111/jnc.14665
Autor:
Sonia Espindola, Jean-Marc Gallo, Juan E. Ferrario, Ana Damianich, Juan E. Belforte, Maria Elena Avale, Manuela Sartor, Rodrigo Javier Alvarez
Publikováno v:
Espíndola, S L, Damianich, A, Alvarez, R J, Sartor, M, Belforte, J E, Ferrario, J E, Gallo, J-M & Avale, M E 2018, ' Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy ', Cell Reports, vol. 23, no. 3, pp. 709-715 . https://doi.org/10.1016/j.celrep.2018.03.079
Cell Reports, Vol 23, Iss 3, Pp 709-715 (2018)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Cell Reports, Vol 23, Iss 3, Pp 709-715 (2018)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
The microtubule-associated protein tau regulates myriad neuronal functions, such as microtubule dynamics, axonal transport and neurite outgrowth. Tauopathies are neurodegenerative disorders characterized by the abnormal metabolism of tau, which accum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a0dbce0308c51c0aeb258585fda120
https://www.sciencedirect.com/science/article/pii/S2211124718304406
https://www.sciencedirect.com/science/article/pii/S2211124718304406
Autor:
M. Elena Avale, Luciana Isaja, Irene Rita Eloisa Taravini, Oscar S. Gershanik, Diane P. Hanger, Gimena Gomez, M. Alejandra Bernardi, Juan E. Ferrario, Ana Damianich, Melina Paula Bordone, Sara Sanz-Blasco
Publikováno v:
Molecular neurobiology. 55(6)
Dopamine replacement therapy with l-DOPA is the treatment of choice for Parkinson’s disease; however, its long-term use is frequently associated with l-DOPA-induced dyskinesia (LID). Many molecules have been implicated in the development of LID, an
Autor:
John K. Chilton, Oleg Lerner, James A. Van Allen, Pranetha Baskaran, Sarah Guthrie, Christopher Clark, Aenea C. Hendry, Mark Hintze, Juan E. Ferrario
Publikováno v:
Proceedings of the National Academy of Sciences. 109:14669-14674
Eye movements depend on correct patterns of connectivity between cranial motor axons and the extraocular muscles. Despite the clinical importance of the ocular motor system, little is known of the molecular mechanisms underlying its development. We h
Autor:
Irene R. E. Taravini, Oscar S. Gershanik, Mariano D. Saborido, Celia Larramendy, Mario Gustavo Murer, Juan E. Ferrario
Publikováno v:
Behavioural Brain Research. 194:44-51
Levodopa-induced dyskinesias are one of the major limiting side effects encountered in the treatment of Parkinson's disease. Dopamine agonists of the D2 family are less prone to induce these abnormal involuntary movements (AIMs), and in some instance